Exocrine Pancreatic Insufficiency
Symptoms, Doctors, Treatments, Advances & More

Exocrine Pancreatic Insufficiency Overview

Save information for later
Sign Up

Learn About Exocrine Pancreatic Insufficiency

Condition 101 content is not available at this time, but we are continually updating the site. Please check back.

However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.

Who are the top Exocrine Pancreatic Insufficiency Local Doctors?
Elite in Exocrine Pancreatic Insufficiency
Gastroenterology
Elite in Exocrine Pancreatic Insufficiency
Gastroenterology
Referral may be required

University Of Pittsburgh Physicians, Department Of Medicine, Division Of Gastroenterology

200 Lothrop Street, Mezzanine Level C Wing, 
Pittsburgh, PA 
Languages Spoken:
English

David Whitcomb, MD, PhD, specializes in gastroenterology and is board-certified in internal medicine by the American Board of Internal Medicine. He is affiliated with UPMC Presbyterian. Dr. Whitcomb completed his fellowship and residencies at the Duke University School of Medicine and medical degree at Ohio State University College of Medicine. Dr. Whitcomb is rated as an Elite provider by MediFind in the treatment of Exocrine Pancreatic Insufficiency. He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses Hereditary Pancreatitis, Chronic Pancreatitis, Acute Pancreatitis, Pancreaticoduodenectomy, and Pancreatectomy. Dr. Whitcomb is board certified in American Board Of Internal Medicine.

Elite in Exocrine Pancreatic Insufficiency
Internal Medicine
Elite in Exocrine Pancreatic Insufficiency
Internal Medicine

BIDMC - Division Of Gastroenterology/GI East

330 Brookline Avenue, Suite Rabb Rose 1, 
Boston, MA 
Languages Spoken:
English
Offers Telehealth

Steven Freedman is an Internal Medicine provider practicing medicine in Boston, Massachusetts. Dr. Freedman is rated as an Elite provider by MediFind in the treatment of Exocrine Pancreatic Insufficiency. He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses Exocrine Pancreatic Insufficiency, Hereditary Pancreatitis, Chronic Pancreatitis, Pancreatectomy, and Pancreaticoduodenectomy. Dr. Freedman is board certified in American Board Of Internal Medicine.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Exocrine Pancreatic Insufficiency
Gastroenterology
Elite in Exocrine Pancreatic Insufficiency
Gastroenterology
Referral may be required

Baylor College Of Medicine - Gastroenterology

7200 Cambridge St, Ste 8B-1, 
Houston, TX 
Languages Spoken:
English, Arabic, Spanish
Accepting New Patients
Offers Telehealth

Dr. Mohamed Othman is the William T. Butler Endowed Chair for Distinguished Faculty and Professor of Medicine, Internal Medicine, Gastroenterology at Baylor College of Medicine. He is also Service Line Chief, Gastroenterology Section at Baylor St Luke's Medical Center; and Member of the Dan L Duncan Comprehensive Cancer Center at Baylor College of Medicine.Dr. Othman’s clinical interests include: endoscopic submucosal dissection, endoscopic mucosal resection, barrett's esophagus surveillance and ablation, chronic and acute pancreatitis, pancreatic cysts, pancreatic cancer screening for high-risk patients, endoscopic ultrasound, ERCP and cholangioscopy with laser; colorectal cancer screening & colonoscopy; per-oral endoscopic myotomy (POEM); gastric per-oral endoscopic myotomy for gastroparesis; and full thickness endoscopic resection.His professional skills cover tissue resection techniques such as ESD and EMR; management of chronic pancreatitis; endoscopic necrosectomy; EUS-assisted ERCP; per oral endoscopic myotomy; management of pancreatic cysts; and management of Barrett's Esophagus.Dr. Othman received his medical degree from the University of Mansoura School of Medicine in Mansoura, Egypt. He completed his residency in Internal Medicine at the University of New Mexico School of Medicine in Albuquerque, where he was also a Gastroenterology and Hepatology Fellow. He also completed a Fellowship in Advanced Endoscopy at the Mayo Clinic Jacksonville in Jacksonville, Florida.Dr. Othman holds certifications from the American Board of Internal Medicine and the American Board of Gastroenterology. He is a member of the American College of Gastroenterology, American Gastroenterology Association, American Society for Gastrointestinal Endoscopy, and American College of Physicians.Among his numerous awards, Dr. Othman received the 2014 Diversity Award from the American Society for Gastrointestinal Endoscopy. Dr. Othman is rated as an Elite provider by MediFind in the treatment of Exocrine Pancreatic Insufficiency. He is also highly rated in 22 other conditions, according to our data. His clinical expertise encompasses Exocrine Pancreatic Insufficiency, Colorectal Polyps, Achalasia, Endoscopy, and Colonoscopy. Dr. Othman is currently accepting new patients.

What are the Latest Advances for Exocrine Pancreatic Insufficiency?
What are the latest Exocrine Pancreatic Insufficiency Clinical Trials?
Etiologic Investigation of Cancer Susceptibility in Inherited Bone Marrow Failure Syndromes: A Natural History Study

Background: A prospective cohort of Inherited Bone Marrow Failure Syndrome (IBMFS) will provide new information regarding cancer rates and types in these disorders. Pathogenic variant(s) in IBMFS genes are relevant to carcinogenesis in sporadic cancers. Patients with IBMFS who develop cancer differ in their genetic and/or environmental features from patients with IBMFS who do not develop cancer. These cancer-...

Match to trials
Find the right clinical trials for you in under a minute
Get started
A Phase 2, Multicenter, Randomized, Active-controlled Study to Assess the Safety and Efficacy of ANG003 at Two Different Dose Levels in Subjects With Exocrine Pancreatic Insufficiency Due to Cystic Fibrosis

Summary: In this study, ANG003, a pancreatic enzyme replacement therapy (PERT; commonly called enzymes), is being investigated as a potential treatment for exocrine pancreatic insufficiency (EPI). People with EPI due to Cystic Fibrosis (CF) may be eligible to participate in this study. The primary objective of this study is to evaluate the safety of ANG003 and see if it works as well compared to Creon, an ...